Deal Snapshot
THERMO FISHER CLOSES USD 1.3BN ACQUISITION OF GENE TESTING FIRM AFFYMETRIX
Friday 01 April 2016

US-based life science company Thermo Fisher Scientific Inc. (NYSE: TMO) has closed its acquisition of US-based gene testing company Affymetrix, Inc. for USD 14.00 per share in cash, for a total purchase price of approximately USD 1.3bn, the company said.
Thermo Fisher won the deal following the approval of Affymetrix shareholders, who joined the company's board in rejecting a rival bid from Origin Technologies Corp., LLC, a newly created entity owned by a group of former Affymetrix executives.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 01/04/2016
Target: Affymetrix Inc
Country: USA
Deal Size: 1.3bn (USD)
Sector: Biotechnology
Type: Corporate acquisition
Financing: Cash
Status: Closed
Vendor:
Buyer: Thermo Fisher Scientific Inc
Buyer Advisor: JP Morgan , Wachtell, Lipton, Rosen and Katz
Comment:
Affymetrix again rejects Origin Technologies overture, turns back to Thermo Fisher deal

Options